Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Featured News

    New York Medical College Awarded BARDA Flu Contract

    By Global Biodefense StaffJune 12, 2014
    Pandemic Influenza Research & Countermeasures
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA) last month awarded a $1.6 million contract to New York Medical College of Valhalla for research in support of influenza countermeasures development and advanced manufacturing.

    Congresswoman Nita M. Lowey (D-Westchester/Rockland), Ranking Democrat on the House Appropriations Committee, said “This particular investment seeks to expedite and enlarge flu vaccine production, so that more and better vaccines are available quicker during high demand. This is a winning formula for strong communities and I will continue my work in Congress to ensure support for scientific research.”

    BARDA is the federal program that facilitates the development of vaccines, drugs, therapies, and diagnostic tools for public health emergencies. The influenza vaccine development project led by Dr. Doris Bucher at New York Medical College seeks to develop influenza vaccine seed strains optimized for high production yields and high immunogenicity.

    The BARDA award, entitled “High Yield (High Growth) Reassortant Seed Influenza Viruses,” was made under a BARDA Broad Agency Announcement for pandemic influenza countermeasures.

    ASPR Awards BARDA HHS Influenza Pandemic Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleIEPHS: Rutgers New Institute for Homeland Security, Preparedness
    Next Article Chem-Bio Coatings: More Than Just a Fresh Coat of Paint

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Healthcare Workers Express Outrage at Flawed CDC Mask Guidance

    September 18, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.